{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:36:20Z","timestamp":1759991780166},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1157\/13078420","type":"journal-article","created":{"date-parts":[[2005,9,14]],"date-time":"2005-09-14T09:37:59Z","timestamp":1126690679000},"page":"281-285","source":"Crossref","is-referenced-by-count":9,"title":["Actividad de la tiopurina metiltransferasa en la enfermedad inflamatoria intestinal. Un estudio en 7.046 pacientes espa\u00f1oles"],"prefix":"10.1016","volume":"125","author":[{"given":"Javier P.","family":"Gisbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Gomoll\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yago","family":"Gonz\u00e1lez-Lama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mar\u00eda Pajares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mat\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis G.","family":"Guijarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13078420_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0210-5705(02)70275-6","article-title":"Preguntas y respuestas sobre el papel de la azatioprina y la 6-mercaptopurina en el tratamiento de la enfermedad inflamatoria intestinal","volume":"25","author":"Gisbert","year":"2002","journal-title":"Gastroenterol Hepatol"},{"key":"10.1157\/13078420_bib2","first-page":"738","article-title":"A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine","volume":"34","author":"Tidd","year":"1974","journal-title":"Cancer Res"},{"key":"10.1157\/13078420_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0014-2565(02)71143-0","article-title":"Terapia individualizada con azatioprina o 6-mercaptopurina mediante monitorizaci\u00f3n de la actividad de la tiopurina metiltransferasa (TPMT)","volume":"202","author":"Gisbert","year":"2002","journal-title":"Rev Clin Esp"},{"key":"10.1157\/13078420_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2125.1999.00884.x","article-title":"Therapeutic drug monitoring of antimetabolic cytotoxic drugs","volume":"47","author":"Lennard","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1157\/13078420_bib5","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity","volume":"32","author":"Weinshilboum","year":"1980","journal-title":"Am J Hum Genet"},{"key":"10.1157\/13078420_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1191\/1352458502ms796oa","article-title":"Thiopurine methyltransferase activity in a spanish population sample: decrease of enzymatic activity in multiple sclerosis patients","volume":"8","author":"Menor","year":"2002","journal-title":"Mult Scler"},{"key":"10.1157\/13078420_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00045391-200105000-00002","article-title":"High 6-thioguanine nucleotide levels and low thiopurine methyltransferase activity in patients with lupus erythematosus treated with azathioprine","volume":"8","author":"Decaux","year":"2001","journal-title":"Am J Ther"},{"key":"10.1157\/13078420_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1157\/13048470","article-title":"Actividad de la tiopurina metiltransferasa y mielotoxicidad debida a azatioprina y 6-mercaptopurina en pacientes con enfermedad inflamatoria del intestino","volume":"121","author":"Gisbert","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13078420_bib9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00007691-200110000-00007","article-title":"Determination of thiopurine methyltransferase activity in human erythrocytes by high-performance liquid chromatography: comparison with the radiochemical method","volume":"23","author":"Menor","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1157\/13078420_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archderm.131.2.193","article-title":"The role of genetic variation in thiopurine methyltransferase activity and the efficacy and\/or side effects of azathioprine therapy in dermatologic patients","volume":"131","author":"Snow","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1157\/13078420_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s002280100267","article-title":"Thiopurine methyltransferase activity in the Jewish population of Israel","volume":"57","author":"Lowenthal","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1157\/13078420_bib12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bjp.0702152","article-title":"Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population","volume":"125","author":"Spire-Vayron de la Moureyre","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1157\/13078420_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0009-9236(96)90169-1","article-title":"Thiopurine methyltransferase activity in a Korean population sample of children","volume":"60","author":"Park-Hah","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1157\/13078420_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s002280050457","article-title":"Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate","volume":"54","author":"Kroplin","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1157\/13078420_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00008571-199208000-00002","article-title":"Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes","volume":"2","author":"Szumlanski","year":"1992","journal-title":"Pharmacogenetics"},{"key":"10.1157\/13078420_bib16","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1111\/j.1572-0241.2000.02256.x","article-title":"Allelic variants of the thiopurine S-methyltransferase deficiency in patients with ulcerative colitis and in healthy controls","volume":"95","author":"Corominas","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13078420_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1365-2036.2002.01177.x","article-title":"Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine","volume":"16","author":"Campbell","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13078420_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00007890-199510150-00003","article-title":"Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients","volume":"60","author":"Mircheva","year":"1995","journal-title":"Transplantation"},{"key":"10.1157\/13078420_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.V121170","article-title":"Long-term results of TMPT activity monitoring in azathioprine-treated renal allograft recipients","volume":"12","author":"Thervet","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1157\/13078420_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s002280100287","article-title":"Human thiopurine S-methyltransferase activity in uremia and after renal transplantation","volume":"57","author":"Weyer","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1157\/13078420_bib21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-199205000-00016","article-title":"The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients","volume":"53","author":"Chocair","year":"1992","journal-title":"Transplantation"},{"key":"10.1157\/13078420_bib22","first-page":"1298","article-title":"Azathioprine myelotoxicity related to elevated 6-thioguanine nucleotides in heart transplantation","volume":"27","author":"Schutz","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1157\/13078420_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/clpt.1987.4","article-title":"Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations","volume":"41","author":"Lennard","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1157\/13078420_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","article-title":"Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia","volume":"336","author":"Lennard","year":"1990","journal-title":"Lancet"},{"key":"10.1157\/13078420_bib25","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood.V85.7.1897.bloodjournal8571897","article-title":"Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia","volume":"85","author":"McLeod","year":"1995","journal-title":"Blood"},{"key":"10.1157\/13078420_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0378-4347(95)00432-7","article-title":"Thiopurine methyltransferase: a review and a clinical pilot study","volume":"678","author":"Keuzenkamp-Jansen","year":"1996","journal-title":"J Chromatogr B Biomed Appl"},{"key":"10.1157\/13078420_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2125.1995.tb04478.x","article-title":"Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine","volume":"39","author":"Szumlanski","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1157\/13078420_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0009-9236(97)90125-9","article-title":"Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction","volume":"62","author":"Lewis","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1157\/13078420_bib29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/gut.49.5.656","article-title":"Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide","volume":"49","author":"Lowry","year":"2001","journal-title":"Gut"},{"key":"10.1157\/13078420_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gut.49.5.665","article-title":"Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease","volume":"49","author":"Lowry","year":"2001","journal-title":"Gut"},{"key":"10.1157\/13078420_bib31","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0016-5085(99)70524-X","article-title":"Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction","volume":"116","author":"Lowry","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1157\/13078420_bib32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/00042737-200111000-00006","article-title":"Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy","volume":"13","author":"Campbell","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1157\/13078420_bib33","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/gast.2002.32420","article-title":"6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease","volume":"122","author":"Dubinsky","year":"2002","journal-title":"Gastroenterology"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775305720194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775305720194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T12:33:35Z","timestamp":1626525215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775305720194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0025775305720194"],"URL":"https:\/\/doi.org\/10.1157\/13078420","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}